An open nominations portal will be managed by UKRI, who will collate information on compounds based on the evidence and data provided by academics, clinicians and industry experts as well as independently sourced information. A core team of due-diligence managers will be responsible for validating the information and will create briefings on potential compounds. This information will feed into the UK CTAP’s specialist sub panels who will triage and prioritise the compounds for consideration by UK-CTAP. If you wish to submit a proposal for a therapeutic to enter RECOVERY+, REMAP-CAP, PRINCIPLE or AGILE , you should complete a proposal form. Following the submission of your proposal you will receive an acknowledgement email with details of the onward process. The proposal form can be found here
Please note: if your recommendation is not made through the proposal form it will not be considered.
If you have any other queries related to COVID-19 therapeutics, please contact therapeuticstaskforce@dhsc.gov.uk.